David Majure, MD

Highlights

1
The American journal of cardiology · 2020
DMDavid Majure
PMID: 33058800PMCID: PMC7550867DOIFirst author62 citations
2
Clinical transplantation · 2024
DMDavid Majure MKMaria Karas EMEvelyn M. Horn YNYoshifumi Naka
PMID: 38952190DOIFirst author

53

4

2 studies

PI
VALganciclovir vs. LETermovir for Primary Prevention of CMV in Moderate to High-Risk Heart Transplant Recipients (The VALET-CMV Study)
PHASE2; PHASE3 · New York Presbyterian Hospital · OPEN TO ACCRUAL (as of 2026)
CMV Viremia; Heart Transplant Infection; Heart Transplant Failure and Rejection
NCT07079735
PI
Feasibility of Using a Consumer Wearable Device to Monitor Hospitalized and Recently-Discharged Heart Failure Patients During Sleep and Daily Activities
New York Presbyterian Hospital · OPEN TO ACCRUAL (as of 2024)

Completed & closed trials (2)

PI
Destination: LVAD vs Heart Transplant in elderly patients eligible for heart_x000D_ transplantation.
NYP/Columbia · IRB STUDY CLOSURE (as of 2026)
PI
DR REGISTRY: Prospective Observational Study of Decongestion in Acute Heart Failure Patients With Insufficient Response to Diuretics
Revamp Medical Ltd. · IRB STUDY CLOSURE (as of 2022)
Acute Decompensated Heart Failure
NCT04877652

NewYork-Presbyterian Expands Heart Transplant and Heart Failure Services
November 1, 2022
NewYork-Presbyterian is expanding its renowned heart transplant program, one of the largest and most experienced heart transplant programs in the nation, and increasing access to its world-class heart failure care.